🔗 Permalink

Inventor profile of:

James A. Russell

City:

Vancouver

Country:

Canada

Published Applications:

Last publication date:

2023-03-02

Top Assignees for applications by James A. Russell

The entities that hold a legal rights for patent applications filed by inventor Russell James A.:

The University of British Columbia 1 Vancouver, Canada
FERRING B.V. 1 Hoofddorp, Netherlands
UNIVERSITY OF BRITISH COLUMBIA 1 Vancouver, Canada
The University of British Columbia 1 Vancouver, BC Canada
SIRIUS GENOMICS INC. 1 Vancouver, BC Canada
University of British Columbia 1 Vancouver, British, Columbia, -

Recent patent applications by Russell James A.

James A. Russell from Vancouver, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-03-02

US20230066056A1

Chemistry; metallurgy

METHODS AND USES FOR PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) INHIBITORS

#2 | 2022-01-13

US20220008499A1

Human necessities

COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING SEPSIS

#3 | 2015-05-21

US20150140005A1

Chemistry; metallurgy

Methods and Uses for Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors

#4 | 2011-07-14

US20110171200A1

Human necessities

PROTEIN C RS2069915 AS A RESPONSE PREDICTOR TO SURVIVAL AND ADMINISTRATION OF ACTIVATED PROTEIN C OR PROTEIN C-LIKE COMPOUND

#5 | 2011-05-12

US20110110930A1

Human necessities

Mitogen-Activated Protein Kinase Kinase Kinase 14 (MAP3K14) Polymorphisms As Indicators of Subject Outcome in Critically Ill Subjects

#6 | 2011-05-05

US20110104683A1

Chemistry; metallurgy

PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) HAPLOTYPES USEFUL AS INDICATORS OF PATIENT OUTCOME

#7 | 2011-02-03

US20110027184A1

Human necessities

PROTEIN C PATHWAY ASSOCIATED POLYMORPHISMS AS RESPONSE PREDICTORS TO ACTIVATED PROTEIN C OR PROTEIN C-LIKE COMPOUND ADMINISTRATION

#8 | 2011-01-27

US20110020825A1

Chemistry; metallurgy

PROTEIN C POLYMORPHISMS USEFUL AS AN INDICATOR OF PATIENT OUTCOME

#9 | 2009-12-03

US20090298711A1

Chemistry; metallurgy

VASOPRESSIN PATHWAY POLYMORPHISMS AS INDICATORS OF SUBJECT OUTCOME IN CRITICALLY ILL SUBJECTS

#10 | 2007-06-07

US20070128594A1

Chemistry; metallurgy

Protein C polymorphisms

#11 | 2006-11-02

US20060246451A1

Chemistry; metallurgy

Plasminogen activator inhibitor-1 (pai-1) haplotypes useful as indicators of patient outcome

InventorID:

1167591 ⎘